Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 1—January 2010
Dispatch

Hepatitis E Epidemic, Uganda

Eyasu H. TeshaleComments to Author , Christopher M. Howard, Scott P. Grytdal, Thomas R. Handzel, Vaughn Barry, Saleem Kamili, Jan Drobeniuc, Samuel Okware, Robert Downing, Jordan W. Tappero, Barnabas Bakamutumaho, Chong-Gee Teo, John W. Ward, Scott D. Holmberg, and Dale J. Hu
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (E.H. Teshale, C.M. Howard, S.P. Grytdal, T.R. Handzel, V. Barry, S. Kamili, J. Drobeniuc, C.-G. Teo, J.W. Ward, S.D. Holmberg, D.J. Hu); Ministry of Health, Republic of Uganda, Kampala, Uganda (S. Okware); Global AIDS Program, Kampala (R. Downing, J.W. Tappero); Ugandan Virus Research Institute, Entebbe, Uganda (B. Bakamutumaho)

Main Article

Table

Symptomatic and serologic evidence of HEV infection, Uganda, June 2008

Characteristic Jaundice
HEV seropositivity
No. examined No. (%) with jaundice No. tested No. (%) seropositive
Age group, y





<2
1,352
92 (6.8)

23
7 (30.4)
2–4
2,213
370 (16.7)

49
28 (57.1)
5–9
3,361
589 (17.5)

59
36 (61.0)
10–14
2,692
504 (18.7)

70
49 (70.0)
15–44
7,155
2,402 (33.6)

189
135 (71.4)
≥45
2,186
816 (37.3)

75
48 (64.0)
Sex





M
9,177
2,017 (22.0)

188
122 (64.9)
F
9,877
2769 (28.0)

277
180 (65.0)
Total 19,098 4789 (25.1) 469 305 (65.0)

*HEV, hepatitis E virus.

Main Article

Page created: March 31, 2011
Page updated: March 31, 2011
Page reviewed: March 31, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external